研究目的
To evaluate the added value of the Tixel drug delivery system (DDS) to the PDL and topical rapamycin treatment for PWS.
研究成果
The use of drug delivery system and topical rapamycin has no remarkable adverse effects, and the addition of Tixel allowed for improved response of PDL and topical rapamycin for port wine stains, that may be related to increased penetration of rapamycin.
研究不足
The small sample size, the comparatively advanced age-range of the sample population, possible different response to treatment in various anatomical distribution and in flat versus hypertrophic PWS, and the need for further studies to explore the possibility of performing same-day procedure of first PDL treatment followed by Tixel then immediate application of rapamycin.
1:Experimental Design and Method Selection:
The study is a retrospective case series of 3 patients with PWS, comparing two treatment regimens: PDL + DDS + Rapamycin vs. PDL + Rapamycin alone.
2:Sample Selection and Data Sources:
Three teenager patients with previously treated PWS with PDL were included. Each stain was divided into two halves for treatment comparison.
3:List of Experimental Equipment and Materials:
Pulsed dye laser (Cynergy, Cynosure Inc, Westford, MA), Tixel (Novoxel, Israel), Rapamycin
4:2% cream. Experimental Procedures and Operational Workflow:
PDL treatment was performed every 4-6 weeks. Tixel treatment was performed once every 2 weeks on half A of every stain. Rapamycin was applied twice daily on the entire stain.
5:Data Analysis Methods:
Clinical examination and photographic documentation were performed at baseline, before each PDL treatment, and four weeks after the last PDL treatment. Four blinded dermatologists evaluated the treatment outcomes using a 5-point scale.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容